title: Immunosuppressive agents and CMV risk in the VICTOR study.
authors.forename: R K
authors.initials: RK
authors.lastname: Avery
authors.forename: B
authors.initials: B
authors.lastname: Kaplan
mesh_terms: D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016377:Organ Transplantation / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D000077562:Valganciclovir
chemical_list: D007166:Immunosuppressive Agents; D000077562:Valganciclovir; D015774:Ganciclovir